U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description

This bioactive compound was named candicidin, because of its high activity on Candida albicans. Candicidin is a polyene antifungal antibiotic produced by a strain of Streptomyces griseus. It is especially effective against Candida albicans (more effective than amphotericin B), and is administered intravaginally in the treatment of vulvovaginal candidiasis. Candicidin inhibits cell membrane of Candida albicans, resulting in disruption of membrane integrity and ultimately cell death. There is some evidence that the binding site in the cell wall may be to fatty acids or fatty acid esters and that this binding capacity must be satisfied before candicidin can bring about its lethal effect by binding to sterol in the cell membrane.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
VANOBID

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Vaginal
In Vitro Use Guide
Candicidin inhibits the growth of a large number of fungi. It inhibits Candida species with 0.5 ug/ml to 50 ug/ml
Substance Class Mixture
Record UNII
48N2IYJ202
Record Status Validated (UNII)
Record Version
Definition References